In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Pocket Guidelines on Atrial Fibrillation

ESC Pocket Guidelines

Arrhythmias, General
Antiarrhythmic Pharmacotherapy
Atrial Fibrillation
Pharmacology and Pharmacotherapy
Invasive Imaging and Functional Assessment
Cardiovascular Pharmacotherapy
Arrhythmias and Device Therapy

Publication Date: 2020

Chairpersons: Gerhard Hindricks & Tatjana Potpara

Order Pocket Guidelines

Table of Contents

  • Introduction.
  • Definition and diagnosis of atrial fibrillation..
  • Epidemiology.
  • Clinical features of atrial fibrillation.
  • Atrial fibrillation subtypes, burden and progression.
  • Screening for AF.
  •  Diagnostic assessment in atrial fibrillation.
  • Integrated management of patients with atrial fibrillation
  • Patient management – the integrated ABC pathway
    • ‘A’ – Anticoagulation/Avoid stroke
    • ’B’ – Better symptom control
    • ’C‘ – Cardiovascular risk factors and concomitant
      diseases – detection and management
  • The ABC pathway in specific clinical settings/conditions/patient populations.
    • Atrial fibrillation with haemodynamic instability
      Acute coronary syndrome, percutaneous coronary intervention
      and chronic coronary syndrome in patients with atrial fibrillation
      Acute stroke or ICH in patients with atrial fibrillation
    • Active bleeding on anticoagulant therapy – management and reversal agents
    • Atrial fibrillation and valvular heart disease.
    • Atrial fibrillation and congenital heart disease
    • Atrial fibrillation during pregnancy
    • Post-operative atrial fibrillation
  • Quality measures and clinical performance indicators in the management of atrial fibrillation.
  • Epidemiology, clinical implications and management of atrial high-rate episodes/subclinical atrial fibrillation